Talk Your Book: Investing in mRNA Technology

Today’s Talk Your Book is brought to you by Direxion:

Michael and I had Managing Director and Head of Product Dave Mazza on the show to talk about Direxion ETFs and their new mRNA-focused ETF.

On today’s show we discuss:

  • Why the mRNA ETF was needed
  • How mRNA was misunderstood
  • The threshold to get into the mRNA ETF
  • How this thematic ETF can be used
  • How to think about investing in biotechs
  • Current events affecting the biotech space
  • mRNA as a technology, incentives, and curing diseases

Listen here:

Books mentioned:




Follow us on FacebookInstagram, and YouTube.

Check out our t-shirts, stickers, coffee mugs, and other swag here.

Subscribe here: